Ecor1 Capital, LLC: holdings and changes

Number 57 of the top 100 funds by copy return. Ecor1 Capital, LLC reported 34 US stocks worth $2.0B for the quarter ending 2026-09-30 and changed 9 new, 8 added, 3 trimmed and 6 sold since 2026-06-30.

Copy return, 4 quarters+44.6%
US 500, same time+14.5%
Size$2.0B
Stocks34

Holdings

StockChangeWeightValueShares
ZYME
Zymeworks INC
29.91%$608M22,970,388
ANAB
Anaptysbio INC
19.47%$396M7,880,094
CGON
Cg Oncology INC
ADD +25%6.52%$133M1,871,892
ETON
Eton Pharmaceuticals INC
ADD +14%6.25%$127M2,470,920
TRAX
First Tracks Biotherapeutics
5.53%$112M3,174,519
AKTS
Aktis Oncology INC
4.62%$94M4,824,469
CRSP
Crispr Therapeutics Ag
3.78%$77M1,389,276
ANRO
Alto Neuroscience INC
BUY2.80%$57M2,232,000
GALAPAGOS NV
Galapagos Nv
2.43%$49M1,667,119
ERAS
Erasca INC Com
ADD +794%2.13%$43M2,950,000
ORIC
Oric Pharmaceuticals INC
TRIM -55%2.01%$41M3,028,116
NGNE
Neurogene INC Com
1.74%$35M1,271,342
ATTO
Attovia Therapeutics INC
BUY1.71%$35M2,024,010
FULC
Fulcrum Therapeutics INC
ADD +4%1.24%$25M6,803,785
ADRX
Adarx Pharmaceuticals INC
BUY1.13%$23M1,150,000
STOK
Stoke Therapeutics INC
ADD +14%1.07%$22M835,000
ZBIO
Zenas Biopharma INC
1.05%$21M789,500
ETRA
Electra Therapeutics INC
BUY0.94%$19M1,700,000
ATRA
Atara Biotherapeutics INC
0.65%$13M1,552,000
CAPR
Capricor Therapeutics INC
BUY0.64%$13M1,376,580
XNCR
Xencor INC
BUY0.61%$12M500,000
ODTX
Odyssey Therapeutics, INC.
0.61%$12M555,555
AURA
Aura Biosciences INC
0.51%$10M1,666,667
NRIX
Nurix Therapeutics INC
ADD +39%0.44%$9M375,000
BRVE
Braveheart Bio INC
BUY0.41%$8M416,700
PHVS
Pharvaris N V
0.37%$8M235,000
EIKN
Eikon Therapeutics INC
ADD +17%0.34%$7M855,634
ELOX
Eloxx Pharmaceuticals INC
0.30%$6M400,000
AARD
Aardvark Therapeutics INC
ADD +82%0.19%$4M720,028
BBOT
Bridgebio Oncology Therapeutics Ord
TRIM -68%0.18%$4M889,607
TCGX
Tcgx Acquisition Corp
BUY0.15%$3M250,000
ZURA
Zura Bio LTD
TRIM -42%0.14%$3M679,715
HLXC
Helix Acquisition Corp III
0.10%$2M200,000
CTNM
Contineum Therapeutics INC
BUY0.04%$900k64,303
LEGN
Legend Biotech Corp
SELL0%was $23M0
MBX
Mbx Biosciences INC
SELL0%was $21M0
RLAY
Relay Therapeutics INC
SELL0%was $13M0
PHAT
Phathom Pharmaceuticals INC
SELL0%was $7M0
MREO
Mereo Biopharma Group PLC
SELL0%was $300k0
SRZN
Surrozen INC
SELL0%was $0k0

Copy return each quarter

HeldFund copyUS 500
2023-09-30 → 2023-12-31+18.0%+11.2%
2023-12-31 → 2024-03-31-2.9%+10.0%
2024-03-31 → 2024-06-30-18.7%+4.0%
2024-06-30 → 2024-09-30-0.9%+5.4%
2024-09-30 → 2024-12-31-11.8%+2.1%
2024-12-31 → 2025-03-31-26.1%-4.6%
2025-03-31 → 2025-06-30-2.1%+10.5%
2025-06-30 → 2025-09-30+41.2%+7.8%
2025-09-30 → 2025-12-31+24.7%+2.4%
2025-12-31 → 2026-03-31+5.6%-4.6%
2026-03-31 → 2026-06-30+15.7%+14.8%
2026-06-30 → 2026-09-30-5.1%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP